---
schema_version: "secwatch.filing_event.v1"
accession: "0001140361-23-028021"
form_type: "8-K"
ticker: "BNGO"
cik: "0001411690"
company_name: "Bionano Genomics, Inc."
filed_at: "2023-06-02T23:59:59+00:00"
generated_at: "2026-06-14T08:05:49.862683+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Bionano Genomics receives Nasdaq delisting notice for bid price below $1.00

## Summary
- Nasdaq notified Bionano on May 30, 2023 that its common stock bid price closed below $1.00 for 30 consecutive days.
- Company has 180 days to regain compliance by having closing bid price at least $1.00 for 10 consecutive business days.
- If not compliant, may be eligible for additional 180-day grace period if other listing standards are met.
- Stock continues to trade under symbol BNGO on Nasdaq Capital Market pending compliance.
- Company intends to monitor and consider options to regain compliance.

## SEC filing metadata
- accession: 0001140361-23-028021
- form_type: 8-K
- ticker: BNGO
- cik: 0001411690
- company_name: Bionano Genomics, Inc.
- filed_at: 2023-06-02T23:59:59+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 3.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1411690/000114036123028021/0001140361-23-028021-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1411690/000114036123028021/brhc20053893_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001140361-23-028021
- JSON: https://secwatch.observer/filing/0001140361-23-028021.json
- Plain text: https://secwatch.observer/filing/0001140361-23-028021.txt

## Key facts
- Listing & Compliance Notices
  Bionano Genomics, Inc. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2), 5810(c)(3)(A)).
  - Exchange: nasdaq
  - Notice: deficiency notice
  - Deficiency: minimum bid price
  - Rules: 5550(a)(2), 5810(c)(3)(A)
  source text: May 30, 2023, Bionano Genomics, Inc. (the “Company”) received a letter (the “Notice”) from The Nasdaq Stock Market LLC (“Nasdaq”) advising the Company that for 30 consecutive trading days preceding the date of the Notice, the bid price of the Company’s common stock had closed below the $1.00 per share minimum required for continued listing on The Nasdaq Capital Market pursuant to Nasdaq Listing Rule 5550(a)(2) (the “Minimum Bid Price Requirement”). The Notice has no effect on the listing of the Company’s common stock at this time, and the Company’s common stock continues to trade on The Nasd
  evidence_url: https://www.sec.gov/Archives/edgar/data/1411690/000114036123028021/0001140361-23-028021-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.